The trajectory of Avascular Necrosis Market growth is strongly influenced by a dual set of drivers: demographic changes and the increasing prevalence of specific lifestyle and medical risk factors. The most significant demographic factor is the global aging population. Although AVN can affect individuals of all ages, the need for surgical intervention (Total Hip Arthroplasty) becomes more urgent and frequent in older adults, who are more susceptible to degenerative joint disease following AVN. This consistent, high-volume demand for joint replacement hardware and associated surgical procedures provides a stable base for market growth. As life expectancy increases, so does the average number of years a person might live with an AVN diagnosis, often necessitating revision surgeries, which further fuels overall Avascular Necrosis Market growth.

Beyond demographics, the increasing incidence of risk factors acts as a critical growth accelerator. High-dose and prolonged corticosteroid use, often for autoimmune conditions or post-transplant care, is a major cause of non-traumatic AVN, and the global use of these potent medications is increasing. Similarly, the expanding prevalence of conditions like HIV, alcohol abuse, and underlying coagulation disorders directly contributes to the AVN patient pool, driving demand for diagnostic and therapeutic services. The rising clinical awareness and improved diagnostic capabilities, particularly the more widespread use of Magnetic Resonance Imaging (MRI) for early detection, also contribute significantly to observed Avascular Necrosis Market growth by identifying previously missed cases. Therefore, the market's expansion is fundamentally driven by the intersecting forces of an aging population requiring joint replacement and a growing pool of at-risk patients requiring early intervention, as detailed in the analysis of Avascular Necrosis Market growth.